The FEI Tribunal has issued its Final Decision on a banned substance case under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
Samples taken on 21 January 2017 from the horse Luke Skywalker 46 (FEI ID 103XB94/USA), ridden by Paige Johnson (FEI ID USA/10013411) at the CSI2* in Wellington (USA), tested positive for the local anaesthetic Pramoxine.
The FEI Tribunal has imposed a one-year suspension. As the athlete had been provisionally suspended from 5 April 2017 for three months, she will now not be eligible to compete until 4 April 2018. The FEI Tribunal also imposed a fine of 2,000 CHF and contribution of 3,000 CHF towards legal costs.
The athlete has appealed the decision to the Court of Arbitration for Sport (CAS). Further details on the FEI Tribunal Decision can be found here.
The FEI has also announced an adverse analytical finding involving the prohibited substance O-Desmethyltramadol, a metabolite of the analgesic Tramadol:
Horse: Dalton Des Hayettes (FEI ID 104TD71/BEL)
Person Responsible: Pascal Van Laethem (FEI ID 10044685/BEL)
Event: CSI2* – Deauville (FRA) on 15-18.06.2017
The athlete has been provisionally suspended from the date of notification (7 August 2017) until the FEI Tribunal renders a decision. The horse has been provisionally suspended for two months. Further details can be found here.